These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22201539)

  • 1. Positron emission tomographic imaging of the cannabinoid type 1 receptor system with [¹¹C]OMAR ([¹¹C]JHU75528): improvements in image quantification using wild-type and knockout mice.
    Herance R; Rojas S; Abad S; Jiménez X; Gispert JD; Millán O; Martín-García E; Burokas A; Serra MÀ; Maldonado R; Pareto D
    Mol Imaging; 2011 Dec; 10(6):481-7. PubMed ID: 22201539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.
    Horti AG; Fan H; Kuwabara H; Hilton J; Ravert HT; Holt DP; Alexander M; Kumar A; Rahmim A; Scheffel U; Wong DF; Dannals RF
    J Nucl Med; 2006 Oct; 47(10):1689-96. PubMed ID: 17015906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.
    Wong DF; Kuwabara H; Horti AG; Raymont V; Brasic J; Guevara M; Ye W; Dannals RF; Ravert HT; Nandi A; Rahmim A; Ming JE; Grachev I; Roy C; Cascella N
    Neuroimage; 2010 Oct; 52(4):1505-13. PubMed ID: 20406692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new high-yield synthetic route to PET CB1 radioligands [11C]OMAR and its analogs.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3704-9. PubMed ID: 22542014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB.
    Burokas A; Martín-García E; Gutiérrez-Cuesta J; Rojas S; Herance JR; Gispert JD; Serra MÁ; Maldonado R
    J Neurochem; 2014 Jul; 130(1):126-35. PubMed ID: 24646401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.
    Fan H; Kotsikorou E; Hoffman AF; Ravert HT; Holt D; Hurst DP; Lupica CR; Reggio PH; Dannals RF; Horti AG
    Eur J Med Chem; 2009 Feb; 44(2):593-608. PubMed ID: 18511157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach.
    Valenta I; Varga ZV; Valentine H; Cinar R; Horti A; Mathews WB; Dannals RF; Steele K; Kunos G; Wahl RL; Pomper MG; Wong DF; Pacher P; Schindler TH
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):320-332. PubMed ID: 29413441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study.
    Takano A; Gulyás B; Varnäs K; Little PB; Noerregaard PK; Jensen NO; Elling CE; Halldin C
    Synapse; 2014 Mar; 68(3):89-97. PubMed ID: 24293119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.
    Neumeister A; Normandin MD; Pietrzak RH; Piomelli D; Zheng MQ; Gujarro-Anton A; Potenza MN; Bailey CR; Lin SF; Najafzadeh S; Ropchan J; Henry S; Corsi-Travali S; Carson RE; Huang Y
    Mol Psychiatry; 2013 Sep; 18(9):1034-40. PubMed ID: 23670490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder function in a cannabinoid receptor type 1 knockout mouse.
    Füllhase C; Campeau L; Sibaev A; Storr M; Hennenberg M; Gratzke C; Stief C; Hedlund P; Andersson KE
    BJU Int; 2014 Jan; 113(1):144-51. PubMed ID: 24053792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors.
    Tsujikawa T; Zoghbi SS; Hong J; Donohue SR; Jenko KJ; Gladding RL; Halldin C; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Jan; 84():733-41. PubMed ID: 24076222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
    Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.
    Yasuno F; Brown AK; Zoghbi SS; Krushinski JH; Chernet E; Tauscher J; Schaus JM; Phebus LA; Chesterfield AK; Felder CC; Gladding RL; Hong J; Halldin C; Pike VW; Innis RB
    Neuropsychopharmacology; 2008 Jan; 33(2):259-69. PubMed ID: 17392732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of the brain cannabinoid receptor.
    Gifford AN; Makriyannis A; Volkow ND; Gatley SJ
    Chem Phys Lipids; 2002 Dec; 121(1-2):65-72. PubMed ID: 12505691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences.
    Normandin MD; Zheng MQ; Lin KS; Mason NS; Lin SF; Ropchan J; Labaree D; Henry S; Williams WA; Carson RE; Neumeister A; Huang Y
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1313-22. PubMed ID: 25833345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
    González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
    Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptors.
    Ahamed M; Verbruggen A; Bormans G
    J Labelled Comp Radiopharm; 2013; 56(3-4):207-14. PubMed ID: 24285327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.
    Volk DW; Eggan SM; Horti AG; Wong DF; Lewis DA
    Schizophr Res; 2014 Oct; 159(1):124-9. PubMed ID: 25107849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
    Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
    J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
    Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.